Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Study findings suggest people with chronic liver disease should be prioritized for booster shots.
Human papillomavirus and hepatitis B vaccines lower the risk of developing cancer.
Disruptions in access to treatment and harm reduction services could set back effort to eliminate hep C in the U.S.
An extra booster dose raised antibody levels in one third of people with organ transplants, but many remain unprotected.
The early cancer is detected, the easier it is to treat.
Studies have shown an alarming drop in screenings—and more advanced cancer—during the COVID-19 pandemic.
Alcoholism-related liver disease was a growing problem even before COVID-19, but the pandemic has dramatically added to the toll.
New report highlights cancer’s toll on racial and ethnic minorities and other underserved populations.
Many people with fatty liver disease have obesity, diabetes and other metabolic conditions.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.